- PR Newswire•2 days ago
HAMILTON, Bermuda, Oct. 19, 2016 /PRNewswire/ -- Roivant Sciences Ltd., an innovative biopharmaceutical company focused on developing promising drug candidates to improve the lives of patients and their families, has expanded its Board of Directors through the appointment of Patrick Machado as its second independent director. Prior to joining the board of Roivant Sciences, Mr. Machado was a co-founder of Medivation and served as its Chief Financial Officer from 2004 to 2014. "We are delighted to welcome Patrick Machado to our board," said Vivek Ramaswamy, Founder and Director of Roivant Sciences.
- Investor's Business Daily•15 days ago
Alnylam stock tanked Thursday after the drugmaker ended testing on an amyloidosis drug after several patients died.
Arbutus Biopharma Corporation (ABUS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Ask||5.20 x 400|
|Day's Range||2.96 - 3.11|
|52wk Range||2.72 - 6.26|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.86|
|Avg Vol (3m)||125,652|
|Dividend & Yield||N/A (N/A)|